Showing results (41-50 of 901) with videos related to
Sort By:
Pageof 91
Antiviral Therapy|June 27, 2007
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis CJohannes Wiegand, Markus Cornberg, Nuray Aslan, et al.Hepatology Communications|September 25, 2021
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis DeltaLisa Sandmann, Cihan Yurdaydin, Katja Deterding, et al.Current Opinion in Virology|January 31, 2016
Hepatitis C virus infection from the perspective of heterologous immunityMarkus Cornberg, Heiner WedemeyerCurrent Opinion in Pharmacology|September 2, 2021
Towards eradication of HBV: Treatment approaches and status of clinical trialsLisa Sandmann, Markus CornbergHelicobacter|September 14, 2004
Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosisJan Hendrik Martin, Andrej Potthoff, Susanne Ledig, et al.Frontiers in Immunology|May 24, 2017
Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus InfectionsDavid F G Malone, Sebastian Lunemann, Julia Hengst, et al.Open Forum Infectious Diseases|February 28, 2020
Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV TherapyBenjamin Schulte, Maximilian Wübbolding, Fiona Marra, et al.European Journal of Immunology|June 15, 2016
Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapyJulia Hengst, Benedikt Strunz, Katja Deterding, et al.Journal of Leukocyte Biology|June 3, 2015
Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphismMagdalena Rogalska-Taranta, Antoaneta A Markova, Andrzej Taranta, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2015
Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world settingChristoph Höner Zu Siederdissen, Benjamin Maasoumy, Katja Deterding, et al.Pageof 91